GE HealthCare Technologies Inc.
Every calculator, already run for GEHC
Open the full toolkit →You have the numbers on GEHC. Get the argument.
A written report on which of these readings actually decide the outcome for GE HealthCare Technologies Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
20 analysts covering GEHCAnalyst Price Target Disagreement for GE HealthCare Technologies Inc.
Wall Street's bull case implies +44% from the current price; the bear case implies +5%. A 39% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for GEHC
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatme…
GEHC — frequently asked
Is GEHC a buy right now?
Wall Street's consensus rating on GE HealthCare Technologies Inc. is Buy across 20 analysts, with a mean price target of $83.05 (+25% vs. the current $66.63). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is GEHC overvalued?
GEHC trades at 15.4x trailing earnings, against a DCF fair value of $99 per share. The current price implies 1% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is GEHC's next earnings date?
GE HealthCare Technologies Inc. is next scheduled to report earnings around Oct 28, 2026. A full GEHC research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for GE HealthCare Technologies Inc.?
Analysts covering GE HealthCare Technologies Inc. (GEHC) range from a bear-case target of $70.00 to a bull-case high of $96.00, with a mean consensus target of $83.05 across 19 analysts. The spread of $26.00 (39% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare GE HealthCare Technologies Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For GE HealthCare Technologies Inc.
Start with the evergreen guides that matter most for Healthcare, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full GEHC research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on GE HealthCare Technologies Inc., in minutes. 3 free reports included with every account — no credit card required.